Oxyntomodulin reduces bodyweight and food intake, and alters levels of adipose hormones in overweight and obese subjects

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1503, 2005-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Orlistat therapy reduces bodyweight and serum lipid levels

By  

Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Sibutramine improves sexual function as well as reducing bodyweight in overweight and obese women

By  

Inpharma, Vol. 1, Iss. 1542, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Low 25 Hydroxyvitamin D Levels are Independently Associated with Autoimmune Thyroiditis in a Cohort of Apparently Healthy Overweight and Obese Subjects

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 6, 2018-11 ,pp. : 646-652

Bentham Science Publishers

Access to resources Recommend Favorite

Sibutramine improves insulin sensitivity and reduces bodyweight in obese patients with type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Bodyweight gain associated with olanzapine use may, at least in part, be caused by increased food intake

By  

Inpharma, Vol. 1, Iss. 1497, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite